Massive NIH–industry project opens portals to target validation
Elie Dolgin • February 27, 2019
Five years in, the US$360 million Accelerating Medicines Partnership is yielding tools to speed up drug discovery for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease.
Continue reading at Nature Reviews Drug Discovery.
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.
A shadow-sensing skill known as skototaxis helps cicadas find trees to molt on.